Study to Investigate the Efficacy and Safety of Dupilumab Administered With Topical Corticosteroids (TCS) in Participants ≥6 to <12 Years With Severe Atopic Dermatitis (AD)
Completed · Phase 3 · Has a placebo group
Conditions studied: Dermatitis, Atopic
In brief
The main objective of the trial is to demonstrate the efficacy of dupilumab administered concomitantly with topical corticosteroids (TCS) in participants ≥6 years to \<12 years of age with severe atopic dermatitis (AD). The secondary objective is to assess the safety of dupilumab administered concomitantly with TCS in patients ≥6 years to \<12 years of age with severe AD.
Key facts
- Study ID
- NCT03345914
- Run by
- Regeneron Pharmaceuticals
- People needed
- 367
- Starts
- 2017-11-17
- Expected to finish
- 2019-09-10
- Last updated by the study team
- 2020-08-13
Who can join
Age: 6 and older, up to 11. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Regeneron Research Site — Gilbert, Arizona, United States
- Regeneron Research Site — Bakersfield, California, United States
- Regeneron Research Site — Long Beach, California, United States
- Regeneron Research Site — Mission Viejo, California, United States
- Regeneron Research Site — Rolling Hills Estates, California, United States
- Regeneron Research Site — San Diego, California, United States
- Regeneron Research Site — Denver, Colorado, United States
- Regeneron Research Site — Coral Gables, Florida, United States
- Regeneron Research Site — Tampa, Florida, United States
- Regeneron Research Site — Tampa, Florida, United States
- Regeneron Research Site — Macon, Georgia, United States
- Regeneron Research Site — Sandy Springs, Georgia, United States
- Regeneron Research Site — Chicago, Illinois, United States
- Regeneron Research Site — Normal, Illinois, United States
- Regeneron Research Site — Rockville, Maryland, United States
- Regeneron Research Site — Ypsilanti, Michigan, United States
- Regeneron Research Site — Minneapolis, Minnesota, United States
- Regeneron Research Site — St Louis, Missouri, United States
- Regeneron Research Site — Forest Hills, New York, United States
- Regeneron Research Site — New York, New York, United States
- Regeneron Research Site — Rochester, New York, United States
- Regeneron Research Site — Gahanna, Ohio, United States
- Regeneron Research Site — Portland, Oregon, United States
- Regeneron Research Site — Philadelphia, Pennsylvania, United States
- Regeneron Research Site — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.